Anbio Biotechnology Class A Ordinary Shares

NNNN· NASDAQ· Health Care· Health Care Equipment & Services

$3.50+4.17%

2026-11-02

Financials

Valuation Metrics

Anbio Biotechnology Class A Ordinary Shares's Market Cap is $154M. At end of 2025 it was $1.32B. Ranked #3017 of 3,116 in US market (top 97%), #1387 of 1,472 on NASDAQ (top 94%), #193 of 203 in Health Care Equipment & Services (top 95%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	$154M	US#3,017/3,116 Sec#193/203
Total Assets	$30M	US#3,077/3,116 Sec#205/203
Net Assets	$30M	US#2,872/3,116 Sec#187/203
Value
P/B	5.09x	US#2,264/3,116 Sec#137/203
P/S	17.77x	US#2,835/3,116 Sec#195/203
Profitability
Revenue Growth	5.64%	US#1,702/3,116 Sec#122/203
Earnings Growth	169.86%	US#174/3,116 Sec#8/203
Financial Health
Debt Ratio	0.29%	US#5/3,116 Sec#1/203
Total Debt	$0.00	US—/3,116 Sec—/203
Cash	$8M	US#2,991/3,116 Sec#202/203
Current Ratio	344.31x	US#18/3,116 Sec#1/203
Performance
1Y Return	-79.23%	US#3,093/3,116 Sec#199/203
1M Return	-36.94%	US#3,069/3,116 Sec#198/203
From 52W High	-92.18%	US#3,111/3,116 Sec#203/203
1Y MDD	-92.39%	US#3,113/3,116 Sec#203/203
Trading
Volume	56,104 shares	US#3,065/3,116 Sec#202/203
Trading Value	$199169.00	US#3,108/3,116 Sec#203/203
Per Share
BPS	$0.69	US#2,727/3,116 Sec#187/203